Strs Ohio Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Strs Ohio increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 95.1% in the second quarter, Holdings Channel reports. The firm owned 164,091 shares of the medical equipment provider’s stock after acquiring an additional 80,004 shares during the period. Strs Ohio’s holdings in Intuitive Surgical were worth $89,169,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $26,000. Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical in the 2nd quarter worth approximately $30,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical in the 1st quarter worth approximately $30,000. Finally, TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on ISRG. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Sunday. Wells Fargo & Company upped their price target on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Truist Financial set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Finally, UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $608.92.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $537.59 on Thursday. The firm has a market cap of $192.72 billion, a price-to-earnings ratio of 71.11, a P/E/G ratio of 5.01 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock has a 50-day simple moving average of $461.96 and a 200-day simple moving average of $498.01.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.84 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 96,011 shares of company stock worth $50,309,042. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.